The purpose of the American Cancer Society/American Society of Clinical Oncology Breast
Cancer Survivorship Care Guideline is to provide recommendations to assist primary care …

Context Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive
and advanced prostate cancer, but it has also been associated with adverse effects on bone …

During the past decade preclinical studies have defined many of the mechanisms used by
tumours to hijack the skeleton and promote bone metastasis. This has led to the …

Background Sipuleucel-T, an autologous active cellular immunotherapy, has shown
evidence of efficacy in reducing the risk of death among men with metastatic castration …

Osteoporosis is a skeletal disorder characterized by decreased mass and compromised
bone strength predisposing to an increased risk of fractures. Although idiopathic …

Background Androgen-deprivation therapy is well-established for treating prostate cancer
but is associated with bone loss and an increased risk of fracture. We investigated the effects …

Objective: The aim was to formulate practice guidelines for management of osteoporosis in
men. Evidence: We used the Grading of Recommendations, Assessment, Development, and …

Context: Osteoporosis and osteopenia are associated with increased fracture incidence.
Objective: The aim of this study was to determine the comparative effectiveness of different …

Drug-induced osteoporosis is a significant health problem and many physicians are
unaware that many commonly prescribed medications contribute to significant bone loss …

Purpose Zoledronic acid decreases the risk for skeletal-related events (SREs) in men with
castration-resistant prostate cancer and bone metastases but its role earlier in the natural …